Finanzen von scPharmaceuticals Inc (SCPH)SCPHscPharmaceuticals Inc

Evaluating the bottom line, scPharmaceuticals Inc maintains a gross margin of 68.76%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -89.11%, while the net margin is -112.36%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SCPH converts its operational activities into shareholder value.

In the context of the broader market, SCPH competes directly with industry leaders such as TKNO and OMER. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SCPH's gross margin of 68.76% stands against TKNO's 37.73% and OMER's 97.20%. Such benchmarking helps identify whether scPharmaceuticals Inc is trading at a premium or discount relative to its financial performance.